Malignant peripheral nerve sheath tumor classification: Difference between revisions
No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
==Classification== | ==Classification== | ||
A '''malignant peripheral nerve sheath tumor''' (MPNST) or '''malignant neurolemmoma''' is a form of [[cancer]] of the [[connective tissue]] surrounding [[nerve]]s. Given its origin and behavior it is classified as a [[sarcoma]]. About half the cases are diagonosed in people with [[neurofibromatosis]]; the lifetime risk for an MPNST in patients with neurofibromatosis type 1 is 8-13% (Evans ''et al'' 2002). The first-line treatmenet is surgical resection with wide margins. [[Chemotherapy]] (e.g. high-dose [[doxorubicin]]) and often [[radiation therapy|radiotherapy]] are done as adjuvant and/or neoadjuvant treatment.<ref name="pmid12011145">{{cite journal |author=Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A |title=Malignant peripheral nerve sheath tumours in neurofibromatosis 1 |journal=[[Journal of Medical Genetics]] |volume=39 |issue=5 |pages=311–4 |year=2002 |month=May |pmid=12011145 |pmc=1735122 |doi= |url=http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=12011145 |accessdate=2012-09-11}}</ref> | A '''malignant peripheral nerve sheath tumor''' (MPNST) or '''malignant neurolemmoma''' is a form of [[cancer]] of the [[connective tissue]] surrounding [[nerve]]s. Given its origin and behavior it is classified as a [[sarcoma]]. About half the cases are diagonosed in people with [[neurofibromatosis]]; the lifetime risk for an MPNST in patients with neurofibromatosis type 1 is 8-13% (Evans ''et al'' 2002). The first-line treatmenet is surgical resection with wide margins. [[Chemotherapy]] (e.g. high-dose [[doxorubicin]]) and often [[radiation therapy|radiotherapy]] are done as adjuvant and/or neoadjuvant treatment.<ref name="pmid12011145">{{cite journal |author=Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A |title=Malignant peripheral nerve sheath tumours in neurofibromatosis 1 |journal=[[Journal of Medical Genetics]] |volume=39 |issue=5 |pages=311–4 |year=2002 |month=May |pmid=12011145 |pmc=1735122 |doi= |url=http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=12011145 |accessdate=2012-09-11}}</ref> | ||
== Classification == | |||
Malignant peripheral nerve sheath tumors are a rare type of cancer that arise from the soft tissue that surrounds nerves. They are a type of sarcoma. Most malignant peripheral nerve sheath tumors arise from the [[nerve plexus]]es that distribute nerves into the limbs—the [[brachial plexus|brachial]] and [[lumbar plexus|lumbar]] plexuses—or from nerves as they arise from the trunk.<ref name="Panigrahi">{{Cite journal | pmid = 24174807| doi = 10.4103/0976-3147.116480| title = Primary malignant peripheral nerve sheath tumor at unusual location| journal = Journal of Neurosciences in Rural Practice| volume = 4| issue = 5| pages = 83| year = 2013| last1 = Panigrahi | first1 = S. | last2 = Mishra | first2 = S. | last3 = Das | first3 = S. | last4 = Dhir | first4 = M. | pmc=3808069}}</ref> | |||
==References== | ==References== |
Revision as of 16:20, 1 December 2015
Malignant peripheral nerve sheath tumor Microchapters |
Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Malignant peripheral nerve sheath tumor classification On the Web |
American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor classification |
FDA on Malignant peripheral nerve sheath tumor classification |
CDC on Malignant peripheral nerve sheath tumor classification |
Malignant peripheral nerve sheath tumor classification in the news |
Blogs on Malignant peripheral nerve sheath tumor classification |
Directions to Hospitals Treating Malignant peripheral nerve sheath tumor |
Risk calculators and risk factors for Malignant peripheral nerve sheath tumor classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Classification
A malignant peripheral nerve sheath tumor (MPNST) or malignant neurolemmoma is a form of cancer of the connective tissue surrounding nerves. Given its origin and behavior it is classified as a sarcoma. About half the cases are diagonosed in people with neurofibromatosis; the lifetime risk for an MPNST in patients with neurofibromatosis type 1 is 8-13% (Evans et al 2002). The first-line treatmenet is surgical resection with wide margins. Chemotherapy (e.g. high-dose doxorubicin) and often radiotherapy are done as adjuvant and/or neoadjuvant treatment.[1]
Classification
Malignant peripheral nerve sheath tumors are a rare type of cancer that arise from the soft tissue that surrounds nerves. They are a type of sarcoma. Most malignant peripheral nerve sheath tumors arise from the nerve plexuses that distribute nerves into the limbs—the brachial and lumbar plexuses—or from nerves as they arise from the trunk.[2]
References
- ↑ Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002). "Malignant peripheral nerve sheath tumours in neurofibromatosis 1". Journal of Medical Genetics. 39 (5): 311–4. PMC 1735122. PMID 12011145. Retrieved 2012-09-11. Unknown parameter
|month=
ignored (help) - ↑ Panigrahi, S.; Mishra, S.; Das, S.; Dhir, M. (2013). "Primary malignant peripheral nerve sheath tumor at unusual location". Journal of Neurosciences in Rural Practice. 4 (5): 83. doi:10.4103/0976-3147.116480. PMC 3808069. PMID 24174807.